World Health Organization
Cancer Resolution at the WHO
May 3, 2017. UACT was among 29 civil society organizations and 33 health professionals, activists, and economists — including Nobel Prize laureate Joseph Stiglitz — asking delegates to the World Health Assembly (WHA) to support a feasibility study on the progressive delinkage of the costs of research and development from the price of cancer medicines.
March 30, 2017. UACT, along with sixteen other civil society groups, sent a letter to the EU High Representative for Foreign Affairs and Security Policy urging that the EU support a World Health Organization resolution that mandates a feasibility study on a fund for cancer research and development that delinks R&D costs from the price of health technologies.
UN High-Level Panel on Access to Medicines
UACT statement on the final report of the UN Secretary-General High-Level Panel on Access to Medicines.
World Trade Organization
WTO pressures on Least Developed Countries
October 19, 2015. UACT, in conjunction with five other allied organizations, submitted a letter to the White House, USTR, and USPTO addressed to President Obama to express the deep concerns with the US opposition of a drug patent waiver for least developed countries (LDCs). The coalition that signed the letter included Oxfam America, Health Gap, Knowledge Ecology International, Public Citizen, Young Professionals Chronic Disease Network, and UACT.
Medicines Patent Pool
UACT statement on the GSK announcement regarding licensing cancer drug patents to the Medicines Patent Pool.